Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide

Yi L. Hwa, Martha Q. Lacy, Morie A. Gertz, Shaji K. Kumar, Eli Muchtar, Francis K. Buadi, David Dingli, Nelson Leung, Prashant Kapoor, Ronald S. Go, Miriam A. Hobbs, Amie L. Fonder, Wilson I. Gonsalves, Rahma Warsame, Taxiarchis V. Kourelis, Susanne R. Hayman, Mustaqeem A. Siddiqui, S. Vincent Rajkumar, Angela Dispenzieri

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)433-436
Number of pages4
JournalEuropean Journal of Haematology
Volume106
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • beta blockers
  • multiple myeloma
  • pomalidomide
  • progression-free survival

ASJC Scopus subject areas

  • Hematology

Cite this